Loading…
Intestinal butyric acid-mediated disruption of gut hormone secretion and lipid metabolism in vasopressin receptor-deficient mice
Arginine vasopressin (AVP), known as an antidiuretic hormone, is also crucial in metabolic homeostasis. Although AVP receptor-deficient mice exhibit various abnormalities in glucose and lipid metabolism, the mechanism underlying these symptoms remains unclear. This study aimed to explore the involve...
Saved in:
Published in: | Molecular metabolism (Germany) 2024-12, Vol.91, p.102072, Article 102072 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | |
container_start_page | 102072 |
container_title | Molecular metabolism (Germany) |
container_volume | 91 |
creator | Harada, Kazuki Wada, Eiji Osuga, Yuri Shimizu, Kie Uenoyama, Reiko Hirai, Masami Yokota Maekawa, Fumihiko Miyazaki, Masao Hayashi, Yukiko K. Nakamura, Kazuaki Tsuboi, Takashi |
description | Arginine vasopressin (AVP), known as an antidiuretic hormone, is also crucial in metabolic homeostasis. Although AVP receptor-deficient mice exhibit various abnormalities in glucose and lipid metabolism, the mechanism underlying these symptoms remains unclear. This study aimed to explore the involvement of the gut hormones including glucagon-like peptide-1 (GLP-1) and microbiota as essential mediators.
We used the mouse GLP-1-secreting cell line, GLUTag, and performed live cell imaging to examine the contribution of V1a and V1b vasopressin receptors (V1aR and V1bR, respectively) to GLP-1 secretion. We next investigated the hormone dynamics of V1aR-deficient mice (V1aR−/− mice), V1bR-deficient mice (V1bR−/− mice), and V1aR/V1bR-double deficient mice (V1aR−/−V1bR−/−mice).
AVP induced the increase in intracellular Ca2+ levels and GLP-1 secretion from GLUTag cells in a V1aR and V1bR-dependent manner. AVP receptor-deficient mice, particularly V1aR−/−V1bR−/− mice, demonstrated impaired secretion of GLP-1 and peptide YY secreted by enteroendocrine L cells. V1aR−/−V1bR−/−mice also exhibited abnormal lipid accumulation in the brown adipose tissue and skeletal muscle. We discovered that V1aR−/−V1bR−/− mice showed increased Paneth cell-related gene expression in the small intestine, which was attributed to increased fecal butyric acid levels. Exposure to butyric acid reduced GLP-1 secretion in L cell line. Additionally, human Paneth cell-related gene expressions negatively correlated with that of V1 receptor genes.
The deficiency in V1 receptor genes may increase gut butyric acid levels and impair the function of L cells, thus dysregulating lipid homeostasis in the brown adipose tissue and skeletal muscle. This study highlights the importance of appropriate control of the gut microbiota and its metabolites, including butyric acid, for the optimum functioning of enteroendocrine cells.
•AVP induces the secretion of gut hormone GLP-1 in enteroendocrine L cells.•AVP receptor-deficient mice show impaired secretion of GLP-1 and PYY from L cells.•AVP receptor deficiency disrupts lipid accumulation in the skeletal muscle and BAT.•Fecal butyric acid levels were increased in AVP receptor-deficient mice.•Chronic exposure to butyric acid disrupts GLP-1 secretion in L cells. |
doi_str_mv | 10.1016/j.molmet.2024.102072 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3146664278</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2212877824002035</els_id><sourcerecordid>3146664278</sourcerecordid><originalsourceid>FETCH-LOGICAL-e1572-1471fc2ed59393b8b04d5ca840b100a822a0cc36ccbcdf95fd9c6ebf92f707663</originalsourceid><addsrcrecordid>eNpNUctKxTAQDaKoqH8gkqWbXpO0TdqNIOILBDe6Dmky1bm0TU1SwZ2fbq5XwdnMMHMYzoOQU85WnHF5sV6NfhghrQQTVV4JpsQOORSCi6JRqtn9Nx-QkxjXLFcjpaz5PjkoWykbJtUh-XqYEsSEkxlot6TPgJYai64YwaFJ4KjDGJY5oZ-o7-nrkuibD6OfgEawAX4OZnJ0wBkdzZxM5weMI8WJfpjo5wAx5jmAhTn5UDjo0SJMiY5o4Zjs9WaIcPLbj8jL7c3z9X3x-HT3cH31WACvlSh4pXhvBbi6LduyazpWudqapmIdZ8w0QhhmbSmt7azr27p3rZXQ9a3oFVNSlkfkfPt3Dv59yZL1iNHCMJgJ_BJ1yavsTiVUk6Fnv9ClyzboOeBowqf-cy0DLrcAyIQ_EIKOG0E2W5ZVJu08as70Jim91tuk9CYpvU2q_AZxgIob</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3146664278</pqid></control><display><type>article</type><title>Intestinal butyric acid-mediated disruption of gut hormone secretion and lipid metabolism in vasopressin receptor-deficient mice</title><source>Elsevier ScienceDirect Journals</source><source>PubMed Central</source><creator>Harada, Kazuki ; Wada, Eiji ; Osuga, Yuri ; Shimizu, Kie ; Uenoyama, Reiko ; Hirai, Masami Yokota ; Maekawa, Fumihiko ; Miyazaki, Masao ; Hayashi, Yukiko K. ; Nakamura, Kazuaki ; Tsuboi, Takashi</creator><creatorcontrib>Harada, Kazuki ; Wada, Eiji ; Osuga, Yuri ; Shimizu, Kie ; Uenoyama, Reiko ; Hirai, Masami Yokota ; Maekawa, Fumihiko ; Miyazaki, Masao ; Hayashi, Yukiko K. ; Nakamura, Kazuaki ; Tsuboi, Takashi</creatorcontrib><description>Arginine vasopressin (AVP), known as an antidiuretic hormone, is also crucial in metabolic homeostasis. Although AVP receptor-deficient mice exhibit various abnormalities in glucose and lipid metabolism, the mechanism underlying these symptoms remains unclear. This study aimed to explore the involvement of the gut hormones including glucagon-like peptide-1 (GLP-1) and microbiota as essential mediators.
We used the mouse GLP-1-secreting cell line, GLUTag, and performed live cell imaging to examine the contribution of V1a and V1b vasopressin receptors (V1aR and V1bR, respectively) to GLP-1 secretion. We next investigated the hormone dynamics of V1aR-deficient mice (V1aR−/− mice), V1bR-deficient mice (V1bR−/− mice), and V1aR/V1bR-double deficient mice (V1aR−/−V1bR−/−mice).
AVP induced the increase in intracellular Ca2+ levels and GLP-1 secretion from GLUTag cells in a V1aR and V1bR-dependent manner. AVP receptor-deficient mice, particularly V1aR−/−V1bR−/− mice, demonstrated impaired secretion of GLP-1 and peptide YY secreted by enteroendocrine L cells. V1aR−/−V1bR−/−mice also exhibited abnormal lipid accumulation in the brown adipose tissue and skeletal muscle. We discovered that V1aR−/−V1bR−/− mice showed increased Paneth cell-related gene expression in the small intestine, which was attributed to increased fecal butyric acid levels. Exposure to butyric acid reduced GLP-1 secretion in L cell line. Additionally, human Paneth cell-related gene expressions negatively correlated with that of V1 receptor genes.
The deficiency in V1 receptor genes may increase gut butyric acid levels and impair the function of L cells, thus dysregulating lipid homeostasis in the brown adipose tissue and skeletal muscle. This study highlights the importance of appropriate control of the gut microbiota and its metabolites, including butyric acid, for the optimum functioning of enteroendocrine cells.
•AVP induces the secretion of gut hormone GLP-1 in enteroendocrine L cells.•AVP receptor-deficient mice show impaired secretion of GLP-1 and PYY from L cells.•AVP receptor deficiency disrupts lipid accumulation in the skeletal muscle and BAT.•Fecal butyric acid levels were increased in AVP receptor-deficient mice.•Chronic exposure to butyric acid disrupts GLP-1 secretion in L cells.</description><identifier>ISSN: 2212-8778</identifier><identifier>EISSN: 2212-8778</identifier><identifier>DOI: 10.1016/j.molmet.2024.102072</identifier><identifier>PMID: 39668067</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Arginine vasopressin ; Butyric acid ; Enteroendocrine cell ; Glucagon-like peptide-1 ; Lipid metabolism</subject><ispartof>Molecular metabolism (Germany), 2024-12, Vol.91, p.102072, Article 102072</ispartof><rights>2024 The Author(s)</rights><rights>Copyright © 2024 The Author(s). Published by Elsevier GmbH.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39668067$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Harada, Kazuki</creatorcontrib><creatorcontrib>Wada, Eiji</creatorcontrib><creatorcontrib>Osuga, Yuri</creatorcontrib><creatorcontrib>Shimizu, Kie</creatorcontrib><creatorcontrib>Uenoyama, Reiko</creatorcontrib><creatorcontrib>Hirai, Masami Yokota</creatorcontrib><creatorcontrib>Maekawa, Fumihiko</creatorcontrib><creatorcontrib>Miyazaki, Masao</creatorcontrib><creatorcontrib>Hayashi, Yukiko K.</creatorcontrib><creatorcontrib>Nakamura, Kazuaki</creatorcontrib><creatorcontrib>Tsuboi, Takashi</creatorcontrib><title>Intestinal butyric acid-mediated disruption of gut hormone secretion and lipid metabolism in vasopressin receptor-deficient mice</title><title>Molecular metabolism (Germany)</title><addtitle>Mol Metab</addtitle><description>Arginine vasopressin (AVP), known as an antidiuretic hormone, is also crucial in metabolic homeostasis. Although AVP receptor-deficient mice exhibit various abnormalities in glucose and lipid metabolism, the mechanism underlying these symptoms remains unclear. This study aimed to explore the involvement of the gut hormones including glucagon-like peptide-1 (GLP-1) and microbiota as essential mediators.
We used the mouse GLP-1-secreting cell line, GLUTag, and performed live cell imaging to examine the contribution of V1a and V1b vasopressin receptors (V1aR and V1bR, respectively) to GLP-1 secretion. We next investigated the hormone dynamics of V1aR-deficient mice (V1aR−/− mice), V1bR-deficient mice (V1bR−/− mice), and V1aR/V1bR-double deficient mice (V1aR−/−V1bR−/−mice).
AVP induced the increase in intracellular Ca2+ levels and GLP-1 secretion from GLUTag cells in a V1aR and V1bR-dependent manner. AVP receptor-deficient mice, particularly V1aR−/−V1bR−/− mice, demonstrated impaired secretion of GLP-1 and peptide YY secreted by enteroendocrine L cells. V1aR−/−V1bR−/−mice also exhibited abnormal lipid accumulation in the brown adipose tissue and skeletal muscle. We discovered that V1aR−/−V1bR−/− mice showed increased Paneth cell-related gene expression in the small intestine, which was attributed to increased fecal butyric acid levels. Exposure to butyric acid reduced GLP-1 secretion in L cell line. Additionally, human Paneth cell-related gene expressions negatively correlated with that of V1 receptor genes.
The deficiency in V1 receptor genes may increase gut butyric acid levels and impair the function of L cells, thus dysregulating lipid homeostasis in the brown adipose tissue and skeletal muscle. This study highlights the importance of appropriate control of the gut microbiota and its metabolites, including butyric acid, for the optimum functioning of enteroendocrine cells.
•AVP induces the secretion of gut hormone GLP-1 in enteroendocrine L cells.•AVP receptor-deficient mice show impaired secretion of GLP-1 and PYY from L cells.•AVP receptor deficiency disrupts lipid accumulation in the skeletal muscle and BAT.•Fecal butyric acid levels were increased in AVP receptor-deficient mice.•Chronic exposure to butyric acid disrupts GLP-1 secretion in L cells.</description><subject>Arginine vasopressin</subject><subject>Butyric acid</subject><subject>Enteroendocrine cell</subject><subject>Glucagon-like peptide-1</subject><subject>Lipid metabolism</subject><issn>2212-8778</issn><issn>2212-8778</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNUctKxTAQDaKoqH8gkqWbXpO0TdqNIOILBDe6Dmky1bm0TU1SwZ2fbq5XwdnMMHMYzoOQU85WnHF5sV6NfhghrQQTVV4JpsQOORSCi6JRqtn9Nx-QkxjXLFcjpaz5PjkoWykbJtUh-XqYEsSEkxlot6TPgJYai64YwaFJ4KjDGJY5oZ-o7-nrkuibD6OfgEawAX4OZnJ0wBkdzZxM5weMI8WJfpjo5wAx5jmAhTn5UDjo0SJMiY5o4Zjs9WaIcPLbj8jL7c3z9X3x-HT3cH31WACvlSh4pXhvBbi6LduyazpWudqapmIdZ8w0QhhmbSmt7azr27p3rZXQ9a3oFVNSlkfkfPt3Dv59yZL1iNHCMJgJ_BJ1yavsTiVUk6Fnv9ClyzboOeBowqf-cy0DLrcAyIQ_EIKOG0E2W5ZVJu08as70Jim91tuk9CYpvU2q_AZxgIob</recordid><startdate>20241211</startdate><enddate>20241211</enddate><creator>Harada, Kazuki</creator><creator>Wada, Eiji</creator><creator>Osuga, Yuri</creator><creator>Shimizu, Kie</creator><creator>Uenoyama, Reiko</creator><creator>Hirai, Masami Yokota</creator><creator>Maekawa, Fumihiko</creator><creator>Miyazaki, Masao</creator><creator>Hayashi, Yukiko K.</creator><creator>Nakamura, Kazuaki</creator><creator>Tsuboi, Takashi</creator><general>Elsevier GmbH</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20241211</creationdate><title>Intestinal butyric acid-mediated disruption of gut hormone secretion and lipid metabolism in vasopressin receptor-deficient mice</title><author>Harada, Kazuki ; Wada, Eiji ; Osuga, Yuri ; Shimizu, Kie ; Uenoyama, Reiko ; Hirai, Masami Yokota ; Maekawa, Fumihiko ; Miyazaki, Masao ; Hayashi, Yukiko K. ; Nakamura, Kazuaki ; Tsuboi, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e1572-1471fc2ed59393b8b04d5ca840b100a822a0cc36ccbcdf95fd9c6ebf92f707663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Arginine vasopressin</topic><topic>Butyric acid</topic><topic>Enteroendocrine cell</topic><topic>Glucagon-like peptide-1</topic><topic>Lipid metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harada, Kazuki</creatorcontrib><creatorcontrib>Wada, Eiji</creatorcontrib><creatorcontrib>Osuga, Yuri</creatorcontrib><creatorcontrib>Shimizu, Kie</creatorcontrib><creatorcontrib>Uenoyama, Reiko</creatorcontrib><creatorcontrib>Hirai, Masami Yokota</creatorcontrib><creatorcontrib>Maekawa, Fumihiko</creatorcontrib><creatorcontrib>Miyazaki, Masao</creatorcontrib><creatorcontrib>Hayashi, Yukiko K.</creatorcontrib><creatorcontrib>Nakamura, Kazuaki</creatorcontrib><creatorcontrib>Tsuboi, Takashi</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular metabolism (Germany)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harada, Kazuki</au><au>Wada, Eiji</au><au>Osuga, Yuri</au><au>Shimizu, Kie</au><au>Uenoyama, Reiko</au><au>Hirai, Masami Yokota</au><au>Maekawa, Fumihiko</au><au>Miyazaki, Masao</au><au>Hayashi, Yukiko K.</au><au>Nakamura, Kazuaki</au><au>Tsuboi, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intestinal butyric acid-mediated disruption of gut hormone secretion and lipid metabolism in vasopressin receptor-deficient mice</atitle><jtitle>Molecular metabolism (Germany)</jtitle><addtitle>Mol Metab</addtitle><date>2024-12-11</date><risdate>2024</risdate><volume>91</volume><spage>102072</spage><pages>102072-</pages><artnum>102072</artnum><issn>2212-8778</issn><eissn>2212-8778</eissn><abstract>Arginine vasopressin (AVP), known as an antidiuretic hormone, is also crucial in metabolic homeostasis. Although AVP receptor-deficient mice exhibit various abnormalities in glucose and lipid metabolism, the mechanism underlying these symptoms remains unclear. This study aimed to explore the involvement of the gut hormones including glucagon-like peptide-1 (GLP-1) and microbiota as essential mediators.
We used the mouse GLP-1-secreting cell line, GLUTag, and performed live cell imaging to examine the contribution of V1a and V1b vasopressin receptors (V1aR and V1bR, respectively) to GLP-1 secretion. We next investigated the hormone dynamics of V1aR-deficient mice (V1aR−/− mice), V1bR-deficient mice (V1bR−/− mice), and V1aR/V1bR-double deficient mice (V1aR−/−V1bR−/−mice).
AVP induced the increase in intracellular Ca2+ levels and GLP-1 secretion from GLUTag cells in a V1aR and V1bR-dependent manner. AVP receptor-deficient mice, particularly V1aR−/−V1bR−/− mice, demonstrated impaired secretion of GLP-1 and peptide YY secreted by enteroendocrine L cells. V1aR−/−V1bR−/−mice also exhibited abnormal lipid accumulation in the brown adipose tissue and skeletal muscle. We discovered that V1aR−/−V1bR−/− mice showed increased Paneth cell-related gene expression in the small intestine, which was attributed to increased fecal butyric acid levels. Exposure to butyric acid reduced GLP-1 secretion in L cell line. Additionally, human Paneth cell-related gene expressions negatively correlated with that of V1 receptor genes.
The deficiency in V1 receptor genes may increase gut butyric acid levels and impair the function of L cells, thus dysregulating lipid homeostasis in the brown adipose tissue and skeletal muscle. This study highlights the importance of appropriate control of the gut microbiota and its metabolites, including butyric acid, for the optimum functioning of enteroendocrine cells.
•AVP induces the secretion of gut hormone GLP-1 in enteroendocrine L cells.•AVP receptor-deficient mice show impaired secretion of GLP-1 and PYY from L cells.•AVP receptor deficiency disrupts lipid accumulation in the skeletal muscle and BAT.•Fecal butyric acid levels were increased in AVP receptor-deficient mice.•Chronic exposure to butyric acid disrupts GLP-1 secretion in L cells.</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>39668067</pmid><doi>10.1016/j.molmet.2024.102072</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2212-8778 |
ispartof | Molecular metabolism (Germany), 2024-12, Vol.91, p.102072, Article 102072 |
issn | 2212-8778 2212-8778 |
language | eng |
recordid | cdi_proquest_miscellaneous_3146664278 |
source | Elsevier ScienceDirect Journals; PubMed Central |
subjects | Arginine vasopressin Butyric acid Enteroendocrine cell Glucagon-like peptide-1 Lipid metabolism |
title | Intestinal butyric acid-mediated disruption of gut hormone secretion and lipid metabolism in vasopressin receptor-deficient mice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T21%3A44%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intestinal%20butyric%20acid-mediated%20disruption%20of%20gut%20hormone%20secretion%20and%20lipid%20metabolism%20in%20vasopressin%20receptor-deficient%20mice&rft.jtitle=Molecular%20metabolism%20(Germany)&rft.au=Harada,%20Kazuki&rft.date=2024-12-11&rft.volume=91&rft.spage=102072&rft.pages=102072-&rft.artnum=102072&rft.issn=2212-8778&rft.eissn=2212-8778&rft_id=info:doi/10.1016/j.molmet.2024.102072&rft_dat=%3Cproquest_pubme%3E3146664278%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-e1572-1471fc2ed59393b8b04d5ca840b100a822a0cc36ccbcdf95fd9c6ebf92f707663%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3146664278&rft_id=info:pmid/39668067&rfr_iscdi=true |